LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global osteoarthritis therapeutics market and the market is poised to grow by USD 2.56 billion during 2019-2023 at a CAGR of about 8% during the forecast period. Request Free Sample Pages
Read the 125-page research report with TOC on "Osteoarthritis Therapeutics Market Analysis Report by Product (Analgesics and NSAIDs, Corticosteroids, Viscosupplements, and Others), by Type (Ankle osteoarthritis, Hip osteoarthritis, Knee osteoarthritis, Shoulder osteoarthritis, and Others), by Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2019 - 2023."
The market is driven by the availability of improved diagnostic modalities. In addition, the expanding research and development is anticipated to further boost the growth of the osteoarthritis therapeutics market.
Traditional imaging techniques such as X-ray imaging are being replaced by magnetic resonance imaging (MRI) methods because they diagnose osteoarthritis more efficiently. MRI helps in visualizing the articular cartilage and other intra-articular structures directly. Similarly, imaging biomarkers are gaining traction along with research activities being conducted in imaging biomarkers-radiographic features, especially Kellgren-Lawrence. These advanced diagnostic modalities improve the diagnosis and consequent treatment of osteoarthritis. Thus, the availability of improved diagnostic modalities is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Osteoarthritis Therapeutics Market Companies:
Bayer AG is headquartered in Germany and operates the business under various segments such as Pharmaceuticals, Consumer Health, Crop Science, and Animal Health. The company offers Aspirin and Aleve.
GlaxoSmithKline plc is headquartered in the UK and offers products through the following business units: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company offers Voltaren and RELAFEN.
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. is headquartered in the US and operates under various business segments, namely Pharmaceutical, Medical devices, and Consumer. The company offers MOTRIN and TYLENOL.
Pfizer Inc. is headquartered in the US and offers products through the following business segments: Innovative Health and Essential Health. The company offers Advil, CELEBREX, FELDENE, and DAYPRO.
Sanofi is headquartered in France and offers products through the following business segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company offers Synvisc and Synvisc-One.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform
Osteoarthritis Therapeutics Product Outlook (Revenue, USD Million, 2019 - 2023)
- Analgesics and NSAIDs
Osteoarthritis Therapeutics Regional Outlook (Revenue, USD Million, 2019 - 2023)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Health Care include:
Osteoporosis Drugs Market – Global Osteoporosis Drugs Market by product (antiresorptive drugs and anabolic drugs) and geography (Asia, Europe, North America, and ROW).
Rheumatoid Arthritis Diagnostic Devices Market – Global Rheumatoid Arthritis Diagnostic Devices Market by product (analyzers and consumables) and geography (Asia, Europe, North America, and ROW).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.